Showing results (351-360 of 782) with videos related to
Sort By:
Pageof 79
The Journal of Biological Chemistry|April 5, 1989
Cooperative function of two separate enhancers of the human epidermal growth factor receptor proto-oncogeneT Maekawa, F Imamoto, G T Merlino, et al.The Journal of Biological Chemistry|August 25, 1975
Guanylate cyclase in Escherichia coli. Purification and propertiesV Macchia, S Varrone, H Weissbach, et al.Gene Therapy|November 3, 1998
Characterization of an MDR1 retroviral bicistronic vector for correction of X-linked severe combined immunodeficiencyS E Kleiman, I Pastan, J M Puck, et al.Archives of Biochemistry and Biophysics|December 1, 1983
Alpha 2-macroglobulin binding to cultured fibroblasts: identification by affinity chromatography of high-affinity binding sitesJ A Hanover, J E Rudick, M C Willingham, et al.Journal of Cellular Physiology|April 1, 1989
An epidermal growth factor-ricin A chain (EGF-RTA)-resistant mutant and an epidermal growth factor-Pseudomonas endotoxin (EGF-PE)-resistant mutant have distinct phenotypesD E Banker, I Pastan, M M Gottesman, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1973
Interrelationship between adenylate cyclase activity, adenosine 3':5' cyclic monophosphate phosphodiesterase activity, adenosine 3':5' cyclic monophosphate levels, and growth of cells in cultureW B Anderson, T R Russell, R A Carchman, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1985
Amplification of DNA sequences in human multidrug-resistant KB carcinoma cellsA T Fojo, J Whang-Peng, M M Gottesman, et al.Proceedings of the National Academy of Sciences of the United States of America|April 1, 1985
Multiply drug-resistant human KB carcinoma cells have decreased amounts of a 75-kDa and a 72-kDa glycoproteinN Richert, S Akiyama, D Shen, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxinV K Chaudhary, M G Gallo, D J FitzGerald, et al.Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificityY Reiter, A Di Carlo, L Fugger, et al.Pageof 79